CRMD CorMedix
CorMedix earnings company data as of 4:48 AM ET 10/23
- 0 of 1 EPS beats
History
2 periods, newest first. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 11 Nov | EPS | — | — | — |
| Rev | — | — | — | ||
| FY2026 Q2 | 13 Aug | EPS | 0.26 | 0.19 | Miss -26.9% |
| Rev | — | $101.9M | — |
Insider trades
Open-market buys and sales by CRMD's executives, directors and 10% owners in the last 12 months, from their Form 4s
- $276K bought by 1 insider
- $1.1M sold by 2 insiders outside a trading plan
- $1.6M sold by 3 insiders under 10b5-1 plans
-
Janet Dillione DirectorPlanned sale$69K 10,000 shares at $6.88 21% of stakeTraded Jan 21 Filed Jan 22
-
Alan W Dunton DirectorPlanned sale$260K 20,000 shares at $13.00 33% of stakeTraded Dec 30, 2025 Filed Jan 2
-
Joseph Todisco CEOPlanned sale$360K 30,000 shares at $12.00 5.6% of stakeTraded Dec 18, 2025 Filed Dec 19, 2025
-
Janet Dillione DirectorPlanned sale$408K 34,000 shares at $12.00 41% of stakeTraded Dec 9, 2025 Filed Dec 11, 2025
-
Steven W Lefkowitz DirectorSale$475K 40,000 shares at $11.88 33% of stakeTraded Dec 9, 2025 Filed Dec 10, 2025
-
Janet Dillione DirectorPlanned sale$467K 46,657 shares at $10.00 49% of stakeTraded Dec 2, 2025 Filed Dec 4, 2025
-
Janet Dillione DirectorSale$262K 26,343 shares at $9.93 35% of stakeTraded Nov 24, 2025 Filed Nov 26, 2025
-
Janet Dillione DirectorSale$343K 30,000 shares at $11.42 38% of stakeTraded Nov 14, 2025 Filed Nov 18, 2025
-
Myron Kaplan DirectorBuy$276K 25,000 shares at $11.02 +14% to stakeTraded Oct 23, 2025 Filed Oct 27, 2025
Also filed in the last 12 months, not counted as buying or selling: 14 stock grants, 14 option exercises, and 12 share withholdings for taxes.
SEC filings
Recent issuer filings from EDGAR, 20 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 8-K | 7.01,9.01 | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 8.01,9.01 | Filing Doc | |
| 8-K | 8.01 | Filing Doc | |
| 8-K | 4.01 | Filing Doc | |
| 8-K | 5.07 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 7.01,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| DEF 14A | PROXY STATEMENT | Filing Doc | |
| DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | Filing Doc | |
| 8-K | 7.01,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 7.01,9.01 | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-K | ANNUAL REPORT | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.